Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. [electronic resource]
Producer: 20031016Description: 206-12 p. digitalISSN:- 0039-6060
- Chromans -- pharmacology
- Humans
- Integrins -- antagonists & inhibitors
- Matrix Metalloproteinase Inhibitors
- Neoplasm Invasiveness -- prevention & control
- Pancreatic Neoplasms -- metabolism
- Prostaglandin D2 -- analogs & derivatives
- Receptors, Cytoplasmic and Nuclear -- metabolism
- Rosiglitazone
- Thiazoles -- pharmacology
- Thiazolidinediones
- Tissue Plasminogen Activator -- antagonists & inhibitors
- Transcription Factors -- metabolism
- Troglitazone
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.